Results 91 to 100 of about 458,313 (258)

A Unique Case of Relapsing Polychondritis Presenting with Acute Pericarditis

Case Reports in Rheumatology, 2013
Relapsing polychondritis (RP) is an inflammatory disease of the cartilaginous tissue primarily affecting the cartilaginous structures of the ear, nose, joints, and the respiratory system.
John V. Higgins, Uma Thanarajasingam, Thomas G. Osborn   +2 more
doaj   +1 more source

Clinical Factors Associated With Pneumocystis Pneumonia Despite Its Primary Prophylaxis: When to Stop Prophylaxis?

Arthritis &Rheumatology, Volume 77, Issue 9, Page 1263-1272, September 2025.
Objective Although previous studies show that primary prophylaxis against Pneumocystis jirovecii pneumonia (PJP) is effective in patients with rheumatic diseases receiving immunosuppressive treatment, there is limited evidence regarding the optimal timing for prophylaxis withdrawal.
Ju Yeon Kim, Se Rim Choi, Jin Kyun Park, Eun Young Lee, Eun Bong Lee, Jun Won Park   +5 more
wiley   +1 more source

Refractory relapsing polychondritis: challenges and solutions

Open Access Rheumatology: Research and Reviews, 2018
Fernando Kemta Lekpa,1,2 Xavier Chevalier3 1Faculty of Health Sciences, University of Buea, Buea, 2Reheumatology Unit, Internal Medicine Department, General Hospital, Douala, Cameroon; 3Department of Rheumatology, Henri Mondor Hospital, University Paris ...
Kemta Lekpa F, Chevalier X
doaj  

Síndrome de Sweet e policondrite recidivante reveladores de síndrome mielodisplásica Sweet's Syndrome and relapsing polychondritis signal myelodysplastic syndrome

Anais Brasileiros de Dermatologia, 2011
Certas dermatoses, pertencentes ao grupo das síndromes paraneoplásicas mucocutâneas, podem ser o prenúncio de uma neoplasia previamente não conhecida. Tanto a síndrome de Sweet como a policondrite recidivante incluem-se neste grupo. A síndrome de Sweet e
Filipa da Encarnação Roque Diamantino, Pedro Manuel Oliveira da Cunha Raimundo, Ana Isabel Pina Clemente Fidalgo   +2 more
doaj   +1 more source

Oral mucosal manifestations with identical mutations to the bone marrow in a patient with VEXAS syndrome

Rheumatology &Autoimmunity, Volume 6, Issue 1, Page 60-62, March 2026.
Lilian Vasaitis, Lena Blomstrand, Tatjana Pandzic, Miklos Gulyas, Panagiotis Baliakas, Viktor Ljungström   +5 more
wiley   +1 more source

Atypical Manifestations of Old World Cutaneous Leishmaniasis: A Systematic Review and Clinical Atlas of Unusual Clinical and Specific Anatomical Presentations

Health Science Reports, Volume 8, Issue 9, September 2025.
ABSTRACT Background and Aims Cutaneous leishmaniasis (CL) represents the most common form of leishmaniasis. It imposes a significant medical burden due to long‐lasting ulcers and disfiguring scars, underscoring the need for comprehensive CL control strategies, particularly in endemic regions.
Bahareh Abtahi‐Naeini, Seyed Naser Emadi, Zabihollah Shahmoradi, Mahsa Pourmahdi‐Boroujeni, Ali Saffaei, Fereshte Rastegarnasab   +5 more
wiley   +1 more source

Diagnostic challenges of bronchiectasis [PDF]

, 2016
Bronchiectasis is a condition of increasing incidence and prevalence around the world. Many different diseases have been associated with bronchiectasis, and their treatment can differ widely.
Agarwal, Agusti, Andonopoulos, Anwar, Barbato, Black, Blasi, Chan, Cohen, Davis, Fenlon, Fujita, Gatheral, Goeminne, Gono, Grenier, Guillermo Suarez-Cuartin, Hurst, James D. Chalmers, Jefferis, Kartalija, King, King, King, Knowles, Knutsen, Lee, Lees, Leigh, Lonni, Mahadeva, Marthin, Martińez-García, Martínez-García, McDonnell, McShane, McShane, Menzies, Mitchell, Ni, Notarangelo, Oriol Sibila, O’Brien, Paganin, Papanikolaou, Park, Parr, Pasteur, Pasteur, Patel, Perry, Quint, Remy-Jardin, Roifman, Rosenzweig, Shah, Shoemark, Similä, Solanki, Stannard, Stockley, Swinson, Valery, Vendrell, Wilczynska   +64 more
core   +2 more sources

VEXAS Syndrome and Substance Use Disorders: A Large‐Scale, Propensity‐Matched, Case‐Control Analysis Revealing Immune‐Mediated Comorbidities

International Journal of Dermatology, Volume 65, Issue 3, Page 584-586, March 2026.
Kritin K. Verma, Kevin T. Nguyen, Daniel P. Friedmann, Helen Chen, Michelle B. Tarbox   +4 more
wiley   +1 more source

Momelotinib Is Effective in Treatment for VEXAS Syndrome: Two Cases Within the AGMT Austrian Myeloid Registry

European Journal of Haematology, Volume 115, Issue 3, Page 299-302, September 2025.
ABSTRACT VEXAS syndrome is caused by somatic mutations in the UBA1 gene and includes features of both autoinflammatory and myeloid diseases. Among several treatment options, JAK inhibitors have proven effective, especially ruxolitinib. However, anemia is often present in VEXAS syndrome.
Dominik Kiem, Michael Leisch, Ildiko Toth, Marie‐Christina Mayer, Lisa Pleyer, Richard Greil, Alexander Egle, Thomas Melchardt   +7 more
wiley   +1 more source

Relapsing Polychondritis: An Updated Review

Biomedicines, 2018
Relapsing polychondritis is an immune-mediated systemic disease characterized by recurrent episodes of inflammation of cartilaginous and proteoglycan-rich tissues, resulting in progressive anatomical deformation and functional impairment of the involved ...
Francesco Borgia, Roberta Giuffrida, Fabrizio Guarneri, Serafinella P. Cannavò   +3 more
doaj   +1 more source